Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 801–900 of 999
Merwass, N. A., Alkhader, Y. K., Alharthi, S. A., Fardan, R. M. A., Alqahtani, A., Mahnashi, F. A., Salam, N. M., Najim, M. M. A., Alenezi, A., & Binobaid, A. O. (2024) · Cureus · doi:10.7759/cureus.63952 · Cited by 18
“Moreover, obesity-induced endoplasmic reticulum (ER) stress in beta cells disrupts normal protein folding and processing, contributing to beta-cell apoptosis and dysfunction [23].”
BackgroundZhang, Y., Gu, X., Lv, H., Wan, D., Wu, Y., & Wu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-93908-3 · Cited by 5
“These alterations contribute to the onset of insulin resistance, which ultimately affects diabetes development 46–48 .”
El-Gohary, O. A. (2017) · American Journal of Biomedical Sciences · doi:10.5099/aj170300127 · Cited by 5
Prediabetes Progression to Diabetes among Veterans with Post Traumatic Stress Disorder
Yaturu, S. (2021) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2022.121004 · Cited by 5
“This glucolipotoxicity with metabolic derangement is secondary to impaired β-Cell function leading to increase in fasting and/or increase in post prandial glucose, release of fatty acids from adipose tissue [23].”
BackgroundLee, S., Choi, S., Hwang, Y. C., Jung, I., Yi, S., Jung, J. G., Ku, J., Jeoung, K., Han, S. J., Kim, H. J., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.023 · Cited by 5
Impact of caffeine on β cell proliferation and apoptosis under the influence of palmitic acid
Chen, L., Yu, M.-A., Shen, T., Xia, J., & Xu, B. L. (2015) · Genetics and Molecular Research · doi:10.4238/2015.may.29.4 · Cited by 5
High-Fat Diets and β-Cell Dysfunction: Molecular Aspects
Collares-Buzato, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00010-5 · Cited by 10
Gallo, S., Raji, A., Calle, R. A., Pong, A., & Meyer, C. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14149 · Cited by 5
“marker of lipotoxicity.(4) The lack of correlation with age and diabetes duration is perhaps surprising because one might expect reduced plasticity of β-cell function in older individuals(34,35) or with longer diabetes duration,(36) which would theoretically limit the magnitude of the improvement in β-cell function.”
BackgroundPetry, S. F., Römer, A., Rawat, D., Brunner, L., Lerch, N., Zhou, M., Grewal, R., Sharifpanah, F., Sauer, H., Eckert, G. P., et al. (2022) · Antioxidants · doi:10.3390/antiox11040788 · Cited by 6
“It is acknowledged that chronic hyperglycemia and elevated FFA exert deleterious effects on the pancreatic β-cell, and continuous advances in research have identified numerous underlying pathways and mechanisms [31,32].”
BackgroundBloomgarden, Z. T. (2011) · Diabetes Care · doi:10.2337/dc11-0591 · Cited by 5
“Oxidative stress is strongly associated with hyperglycemia (37) and with elevations in FFA and reduces insulin gene expression, with improvement seen after antioxidant administration (38).”
BackgroundGrowth Factor Mediated Regulation of Beta Cell Survival
Vasavada, R. C. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010078 · Cited by 6
Lipid Metabolic Disorders: a Pivotal Driver in Type 2 Diabetes Mellitus Pathogenesis
Wu, J., Wang, H., Fu, M., Zhang, M., Zhao, G., & Yu, B. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00732-5 · Cited by 4
“…protein kinase (MAPK) signaling pathway, suppressing the expression of key transcription factors (e.g., pancreatic and duodenal homeobox 1 [PDX1], Musculoaponeurotic fibrosarcoma oncogene homolog A [MAFA]) and disrupting insulin gene transcription, mRNA stability, and protein synthesis [59, 60].”
Sytsma, T. T., Greenlund, L. S., Fischer, K. M., & McCoy, R. G. (2023) · Clinical Diabetes · doi:10.2337/cd22-0124 · Cited by 6
Lv, G., Wang, D., Huang, Y., Shi, R., Qin, C., Chen, X. D., Zeng, X., Luo, H., Yang, P., Chen, S., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1487974 · Cited by 5
Majeed, R., & Mahmood, A. K. (2023) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2024/12.1.32.43 · Cited by 4
Rakshit, K., Brown, M., Javeed, N., Lee, J., Ördög, T., & Matveyenko, A. V. (2024) · iScience · doi:10.1016/j.isci.2024.111179 · Cited by 5
β cells keep bad epigenetic memories of palmitate
Fradin, D., & Bougneres, P. F. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-104 · Cited by 4
Sałat, K., Głuch‐Lutwin, M., Nawieśniak, B., Gawlik, K., Pawlica-Gosiewska, D., Witalis, J., Kazek, G., Filipek, B., Librowski, T., Więckowski, K., et al. (2014) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2013.879973 · Cited by 4
The β-cell burden index of food: A proposal
Scazzina, F., Dei, A., Rio, D. D., Brighenti, F., & Bonadonna, R. C. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.04.015 · Cited by 5
“basic components of the insulin-glucose loop, at least in part through the complex biologic processes named lipotoxicity and glucotoxicity (13), which in turn affect the pathways”
BackgroundSchmudlach, A., Felton, J. A., Kennedy, R. T., & Dovic̀hi, N. J. (2016) · The Analyst · doi:10.1039/c6an02268e · Cited by 4
Takahara, M., Shiraiwa, T., Katakami, N., Matsuoka, T., & Shimomura, I. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0222 · Cited by 4
“It is reported that not only hyperglycemia but also hyperlipidemia affect insulin secretary capacity as well as insulin sensitivity [10, 11].”
BackgroundCarbohydrates: Not All that Bad?
Lin, S., Zhang, C., & Lin, S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.004 · Cited by 4
LDB1-mediated transcriptional complexes are sensitive to islet stress
Liu, Y.-P., Kepple, J. D., Shalev, A., & Hunter, C. S. (2021) · Islets · doi:10.1080/19382014.2021.2016028 · Cited by 4
Alkhateeb, H. H., & Al‐Duais, M. (2022) · Journal of Herbmed Pharmacology · doi:10.34172/jhp.2022.24 · Cited by 5
“Due to impaired glucose metabolism, hyperglycemia causes various metabolic alterations, including oxidative stress (23), which can be defined as an imbalance between free radical formation and antioxidant defence capacity, subsequently causing lipid peroxidation (18,23).”
BackgroundKowluru, A. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115889 · Cited by 4
Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome
Ge, M., Molina, J., Tamayo, I. M., Zhang, G., Kim, J., Njeim, R., Fontanesi, F., Pieper, M. P., Merscher, S., Sharma, K., et al. (2024) · Kidney360 · doi:10.34067/kid.0000000000000472 · Cited by 5
“44,45 Thus, we can speculate that the intrarenal accumulation of lipids, glucose, and their metabolites may cause glucolipotoxicity 46 and that it is necessary to achieve a reduction in both lipid and glucose content in the kidney to prevent disease progression in AS.”
BackgroundInflammatory Pathways Linked to Beta Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_30-2 · Cited by 6
Meenakshisundaram, R., Piumelli, N., Pierpaoli, L., & Gragnoli, C. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-90 · Cited by 4
Arslan, S., & Şanlıer, N. (2016) · Journal of Human Sciences · doi:10.14687/jhs.v13i2.3737 · Cited by 3
Andrestian, M. D., Damanik, M. R. M., Anwar, F., & Yuliana, N. D. (2019) · Jurnal Gizi dan Pangan · doi:10.25182/jgp.2019.14.3.149-156 · Cited by 5
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Prato, S. D., Bianchi, C., & Daniele, G. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch12 · Cited by 14
Miya, A., Nakamura, A., Nomoto, H., Kameda, H., & Atsumi, T. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0525 · Cited by 3
Gao, Y., Gao, C., Zhu, J., & Han, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1774965 · Cited by 4
“In this lipotoxic environment, even modest elevations in FPG may re fl ect early pancreatic b -cell compensatory failure (24).”
Human Pancreatic Islets React to Glucolipotoxicity by Secreting Pyruvate and Citrate
Perrier, J., Nawrot, M., Madec, A., Chikh, K., Chauvin, M., Damblon, C., Sabatier, J., Thivolet, C. H., Rieusset, J., Rautureau, G. J. P., et al. (2023) · Nutrients · doi:10.3390/nu15224791 · Cited by 4
“Chronic exposure to high glucose concentration reduces beta-cell ATP production, altering insulin content (IC) and secretion in pancreatic islets and the beta-cell line [11–13].”
BackgroundHe, T.-B., Bao, Y., Liu, H.-J., Jiang, J.-N., Jiang, G. D., Xu, D. H., Shen, X.-J., Yang, Q., & Hu, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136413 · Cited by 4
Biyikoglu, H., Robertson, M. D., & Collins, A. L. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03646-5 · Cited by 3
“Additionally, heightened intracellular NEFA levels can temporarily overload mitochondria, leading to dysfunction, excessive reactive oxygen species (ROS) production, and accumulation of lipotoxic intermediates, disrupting insulin signalling contributing to insulin resistance across tissues [47–49].”
Liu, X., Xie, Y., Yang, S., Jiang, C., Shang, K., Luo, J., Zhang, L., Hu, G., Liu, Q., Yue, B., et al. (2025) · eLife · doi:10.7554/elife.104355.4 · Cited by 5
Perspectivas da terapia com células-tronco para o diabetes mellitus tipo 2
Leal, A. M. O., & Voltarelli, J. C. (2010) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842010005000088 · Cited by 5
Antioxidants, Healthy Diet, and Diabetes
Pitocco, D., Martini, F., Zaccardi, F., & Ghirlanda, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00024-3 · Cited by 6
Cao, C., Han, Y. Y., Deng, H., Zhang, X., Hu, H., Zha, F., & Wang, Y. (2024) · European journal of medical research · doi:10.1186/s40001-024-02121-x · Cited by 3
Treatment of Type 2 Diabetes in Patients with Obesity
Guzman, H., Hasan, L. Z., & Reid, T. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.10.004 · Cited by 4
Pitocco, D., Martini, F., Scavone, G., Zaccardi, F., & Ghirlanda, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_151 · Cited by 4
Castex, F., Leroy, J., Broca, C., Mezghenna, K., Duranton, F., Lavallard, V., Lebreton, F., Gross, R., Wojtusciszyn, A., & Lajoix, A. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13026 · Cited by 4
Sotorník, R., Suissa, R., & Ardilouze, J. (2022) · Clinical Diabetes · doi:10.2337/cd21-0044 · Cited by 3
Basavarajappa, H. D., Irimia, J. M., Bauer, B. M., & Fueger, P. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043308 · Cited by 3
“To clarify the 75 mechanisms underlying diabetogenic beta cell death, we sought to identify Mig6 associating 76 partners in a GLT cell culture model, which mimics the diabetic milieu [31, 32].”
BackgroundKlöppel, E., de Souza, M. R., Barco, V. S., Gallego, F. Q., Sinzato, Y. K., Corrente, J. E., Rodrigues, T., Volpato, G. T., & Damasceno, D. C. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01217-9 · Cited by 3
Boden, G. H. (2012) · Diabetes · doi:10.2337/db11-1613 · Cited by 3
Islet and Pancreas Transplantation
Ciancio, G., Pugliese, A., Burke, G. W., & Ricordi, C. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_23 · Cited by 3
Diabetes mellitus – um «continuum» fisiopatológico
Guelho, D., Paiva, I., & Carvalheiro, M. C. (2013) · Endocrinology Insights · doi:10.1016/j.rpedm.2013.05.002 · Cited by 27
Sarmiento, E. G., Mena-Bernal, M. C. H., & Galiana, L. I. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73212-0 · Cited by 3
Metabolic Syndrome Biomarkers in Type II Diabetic Ethiopian Patients
Tadesse, F. G. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000139 · Cited by 3
“Deterioration into impaired glucose tolerance occurs when either IR increases or the insulin secretory response of the β-cells decreases, or both [3].”
BackgroundEffects of Experimental Diabetes and Gliclazide on Pregnant Albino Rats and Their Pups
El‐Sayyad, H. I., El-Shershaby, E. M., & Saleh, D. F. (2013) · Journal of internal medicine research · doi:10.12966/jimr.5.4.2013 · Cited by 3
da Silva, T. A., de Carvalho-Filho, C. J., Barroqueiro, E. S. B., das Chagas, D. C., do Nascimento, F. R. F., & Guerra, R. N. M. (2016) · Food and Nutrition Sciences · doi:10.4236/fns.2016.710086 · Cited by 3
Study of type 2 diabetes management among patients in a Macau primary care setting
Wong, I. (2019) · Family Medicine and Community Health · doi:10.1136/fmch-2018-000031 · Cited by 3
Mechanisms of regulation of islet function by NADPH oxidase
Syed, I. (2011) · Human Biology · Cited by 3
Ülger, Y., & Delik, A. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01625-y · Cited by 3
“…2002; Beltran et al. 2010; Ishihara et al. 2019), neurodegenerative disorders (Choi and Choi 2005 ; Carvalho and Cardoso 2021 ), gastroduo - denal ulcers (Bhattacharyya et al. 2014 ), diabetes (Poitout and Robertson 2008), and colorectal cancer (Bhattacharyya et al. 2014; Tian et al. 2017).”
Bai, B., Li, J., Wang, Z., Yang, Y., He, J., Chen, G., Zhang, Y., Qi, Y., Wan, Z., Cai, L., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70070 · Cited by 4
Zhang, S., Shen, Z. X., Cao, P., Ni, S., & Wang, D. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-026-03830-4 · Cited by 2
“Glucolipotoxicity, characterized by elevated levels of both glucose and lipids, induces cytotoxicity in trophoblast cells, impairing their metabolic functions and promoting apoptosis [13].”
Dinatale, B., González, F. B., Bottasso, O., & Pérez, A. R. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102028 · Cited by 2
Monoacylglycerol as a Metabolic Coupling Factor in Glucose-Stimulated Insulin Secretion
Zhao, S., Iglesias, J., Mugabo, Y., Peyot, M., Joly, E. C., Madiraju, S. R. M., & Prentki, M. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.019 · Cited by 2
“But if these rates of esterfication and lipolysis are not balanced, many lipid derivatives may accumulate and induce beta cell dysfunction (Poitout and Robertson, 2008; Prentki et al., 2002; Prentki and Madiraju, 2008).”
BackgroundDiabetes Type 2 (Noninsulin-Dependent Diabetes Mellitus) ☆
Robertson, R. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.03462-3 · Cited by 2
Self-citationOquendo, M. B., Layer, N., Wagner, R., Krippeit‐Drews, P., & Drews, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2094-8 · Cited by 2
“In contrast to our observation many studies assume that ROS production is the essential step underlying the toxicity of excess glucose and lipids (for review see [35]).”
BackgroundResultInfluentialType 2 Diabetes-Etiology, Epidemiology, Pathogenesis, Treatment
Burns, C., & Francis, N. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_34-3 · Cited by 3
Guo, R., Li, Y., Jiang, Y., Khan, M. W., Layden, B. T., & Song, Z. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00027.2025 · Cited by 2
Nguyen, V. H., Nguyen, H. T. T., Le, N. T., Tran, T., Nguyen, L. T. T., Mai, T. P., Pham, P. X., Pham, A. V. T., & Nguyen, H. T. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70081 · Cited by 3
Is there a paradigm shift in preventing diabetic heart failure? A review of SGLT2 inhibitors
KHAKDE, S., Jawaid, H., Yasmin, F., Ali, M. B., & REHMAN, A. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03221-6 · Cited by 2
The role of hormonal treatment in type 2 diabetes mellitus
Imam, S. K. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s49625 · Cited by 3
“Despite all the odds and barriers to insulin therapy, certain population would clearly benefit from early insulinization.(55) Glucotoxicity can be reversed after institution of insulin and achieving normoglycemia, and beta cells recover to a much greater extent in those exposed to shorter duration of hyperglycemia.”
Pancreatic Islet Adaptation and Failure in Obesity and Diabetes
Doliba, N. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_27-1 · Cited by 2
Role of Sugar Intake in Beverages on Overweight and Health
Lafontan, M. (2010) · Nutrition Today · doi:10.1097/nt.0b013e3181fe419e · Cited by 3
“When glucose is in excess, instead of flowing uniquely and normally through oxidative phosphorylation, metabolites overflow into alternative pathways causing oxidative stress and leading to "-cell dysfunction.(15)”
BackgroundSignificance of Organ Crosstalk in Insulin Resistance and Type 2 Diabetes
Bhatt, S., & Kulkarni, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00017-8 · Cited by 3
Volatile Components of Asparagus cochinchinensis Stems
Yin, Z., Zhang, J., & Kang, W. (2016) · Chemistry of Natural Compounds · doi:10.1007/s10600-016-1879-x · Cited by 2
Volatile Composition of Jatropha podagrica Seeds and Flowers
Yin, Z., Zhang, J., & Kang, W. (2017) · Chemistry of Natural Compounds · doi:10.1007/s10600-017-1938-y · Cited by 2
Bioenergetics and Type 2 Diabetes
Doliba, N. M. (2017) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000222 · Cited by 2
Abu-Amara, T. M. M., & Gebaly, Z. M. (2012) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2012.16228 · Cited by 3
Antidiabetic Principle in Cucumis sativus L.
Ibitoye, O. B., Olakunle, A. T., Titilola, A. A., Oyegoke, R. A., Muritala, H. F., & Abubakar, F. A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96393 · Cited by 3
Kowluru, A., Gamage, S., Hali, M., & Gleason, N. F. (2022) · Cellular Physiology and Biochemistry · doi:10.33594/000000557 · Cited by 2
“…active sphingolipids, and pro-inflammatory cytokines) results in significant alterations in cellular function, including induction of oxidative and endoplasmic reticulum (ER) stress, stress kinase activation, mitochondrial dysfunction, and nuclear collapse leading to cell demise [1-10].”
Srivastava, R., Horwitz, M. J., Hershko‐Moshe, A., Bronstein, S., Ben‐Dov, I. Z., & Melloul, D. (2023) · The FASEB Journal · doi:10.1096/fj.202201984r · Cited by 2
Epigenetics of diabetes in humans
Kowluru, R. A., & Kowluru, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00009-9 · Cited by 2
Lusby, A. L. (2009) · Cited by 2
Sijens, P. E. (2015) · Wiley eBooks · doi:10.1002/9780470034590.emrstm1470 · Cited by 2
Truchan, N. A., Sandhu, H. K., Fenske, R. J., Buchanan, R., Moeller, J. R., Reuter, A., Harrington, J., & Kimple, M. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/670000 · Cited by 2
“Insulin resistance, often found with obesity, necessitates the hyperproduction and processing of proinsulin into mature insulin in order to augment insulin secretory capacity, causing significant mitochondrial oxidative and ER stress [8-10].”
BackgroundSpatial molecular imaging of the human type 2 diabetic isletPreprint
Kolar, G. R., Ross, D., Killingbeck, E. E., Samson, W. K., & Yosten, G. L. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.04.519955 · Cited by 2
Abnormalities of Insulin Secretion and β‐Cell Defects in Type 2 Diabetes
Prato, S. D., Bianchi, C., & Daniele, G. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch16 · Cited by 5
Single-cell and spatial characterization of the human pancreas in cystic fibrosis
Mummey, H. M., Corban, S., Lucero, J. D., Melton, R. L., Pittigher, M., Johnston, V. C., Deutsch, G. H., D’Antonio‐Chronowska, A., Wang, A. S., Hull-Meichle, R. L., et al. (2026) · Cell Reports · doi:10.64898/2025.12.14.694120 · Cited by 3
Clinical Approaches to Preserving β-Cell Function in Diabetes
WAJCHENBERG, B. L., & de Carvalho, R. M. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_17 · Cited by 1
Zhou, J., Shi, Y., Zhao, L., Wang, R., Luo, L., & Yin, Z. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117206 · Cited by 1
Meta-analysis of TCF7L2 and SLC30A8 gene polymorphisms concerning type 2 diabetes risk
Muruganantham, J. K., & Veerabathiran, R. (2025) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-025-00464-3 · Cited by 1
An overview of recent developments in clinical trials of anti-diabetic drugs
Madhuri, Y. B., Saifullah, Q., Pandey, M., & Bhattamisra, S. K. (2025) · Panminerva Medica · doi:10.23736/s0031-0808.25.05314-5 · Cited by 1
Archana, P., Kumar, T. D. A., Ganesh, N. V., Mohammed, M., Tavanoji, H. P., Deepikarani, R., & Kumar, B. R. P. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118393 · Cited by 2
Pursuing remission in type 2 diabetes: Competing strategies or complementary paths?
Koufakis, T., Sarafidis, P. A., Τσάπας, Α., & Doumas, M. N. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70212 · Cited by 2
“33 Incretin-based therapies contribute by amplifying satiety and insulinotropic signalling, while metabolic surgery triggers additional changes that extend beyond caloric restriction alone, including shifts in bile acid metabolism, gut microbiota and gut – brain neural pathways.”
Mailloux‐Salinas, P., Jiménez‐Martínez, C., Arias‐Chávez, D. J., Gordillo-Bernal, A. A., Cid‐Gallegos, M. S., Alamilla‐Beltrán, L., & Bravo, G. (2025) · Molecules · doi:10.3390/molecules30244673 · Cited by 1
“The absence of this effect in obese groups (Ob-CS and HE-Ob-CS) suggests that an adverse metabolic environment, characterized by lipotoxicity and chronic inflammation, may exceed or limit the proliferative capacity induced by treatment, compromising the regenerative response of the pancreas [38].”
Park, J., Nguyen, T. N., Shim, H. M., Bae, Y., Yu, G. I., Kang, J., Ha, E. Y., & Cho, H. (2026) · Antioxidants · doi:10.3390/antiox15020150 · Cited by 1
“Excessive glucose and lipid exposure induce mitochondrial dysfunction, increase reactive oxygen species (ROS), and impair ATP generation, ultimately reducing insulin secretory responses [17–19].”
Beyond Glucose: The Overlooked Role of Lipids in Gestational Diabetes
Scairati, R., Laudisio, D., Imperatore, O., Masulli, M., & Colao, A. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104758 · Cited by 2
Reversal of type 2 diabetes through metabolic restoration: A narrative review
Snouda, S. (2026) · Journal of Metabolic Health · doi:10.4102/jmh.v9i1.149 · Cited by 1
Kimura, T., Kidokoro, K., Iwamoto, Y., Iwamoto, H., Sugisaki, T., Itoh, T., Fushimi, Y., Sanada, J., Shimoda, M., Nakanishi, S., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06825-z · Cited by 1
Danial, N. N. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976094.019 · Cited by 1
A Model of Chronic Nutrient Infusion in the Rat
Fergusson, G., Éthier, M., Zarrouki, B., Fontès, G., & Poitout, V. (2013) · Journal of Visualized Experiments · doi:10.3791/50267 · Cited by 1
Self-citationType 2 Diabetes-Etiology, Epidemiology, Pathogenesis, Treatment
Burns, C., & Sirisena, I. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_34-1 · Cited by 1
Advancing Islet Transplantation: From Donor to Engraftment
Sabek, O. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45433-7_10 · Cited by 1
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.